Cellular therapies trial design
Executive Summary
Early-phase clinical trial design for cellular therapies intended for cardiac diseases will be discussed by FDA's Biological Response Modifiers Advisory Committee March 18-19. The meeting will begin at 8:30 a.m. on both days at the Hilton in Silver Spring, Md.; the meeting's second day is scheduled to end at 3 p.m. [To sign up for a webcast of the meeting, visit FDAAdvisoryCommittee.com]...